{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:25:02Z","timestamp":1768451102192,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI22C0360"],"award-info":[{"award-number":["HI22C0360"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145859","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T11:09:59Z","timestamp":1751972999000},"page":"145859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Development of a novel CD3\u03b5-specific human antibody for selective modulation of T cell activation"],"prefix":"10.1016","volume":"320","author":[{"given":"Ha Rim","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Lim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunbo","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukmook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145859_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0301-0082(01)00009-0","article-title":"Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines","volume":"65","author":"Schwartz","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12170","article-title":"Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation","volume":"259","author":"Smigiel","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1007078","article-title":"Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus","volume":"13","author":"Ohmes","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041189","article-title":"Modulating T cell responses by targeting CD3","volume":"15","author":"Menon","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s42003-021-02995-1","article-title":"The interplay between membrane topology and mechanical forces in regulating T cell receptor activity","volume":"5","author":"Al-Aghbar","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-immunol-042617-053429","article-title":"Cell biology of T cell receptor expression and regulation","volume":"36","author":"Alcover","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41423-020-0367-1","article-title":"Structural understanding of T cell receptor triggering","volume":"17","author":"Xu","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0055","first-page":"E5891","article-title":"Ionic CD3\u2212Lck interaction regulates the initiation of T-cell receptor signaling","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Am. Acad. Arts Sci."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00076","article-title":"T cells and gene regulation: the switching on and turning up of genes after T cell receptor stimulation in CD8 T cells","volume":"7","author":"Conley","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1574884712666170809124728","article-title":"Monoclonal antibodies: a review","volume":"13","author":"Singh","year":"2018","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000184433","article-title":"Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejection","volume":"46","author":"Norman","year":"1987","journal-title":"Nephron"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0075","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1991.18","article-title":"OKT3 first-dose reaction: association with T cell subsets and cytokine release","volume":"39","author":"Gaston","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0080","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4239\/wjd.v15.i8.1793","article-title":"Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: a systematic review","volume":"15","author":"Buddhavarapu","year":"2024","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0085","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007890-199908270-00020","article-title":"HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro","volume":"68","author":"Cole","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0090","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0095","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI16090","article-title":"Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3\u03b31 (ala-ala)","volume":"111","author":"Herold","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0100","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.4049\/jimmunol.1103803","article-title":"An antibody to the sixth Ig-like domain of VCAM-1 inhibits leukocyte transendothelial migration without affecting adhesion","volume":"189","author":"Lee","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1271508","article-title":"A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants","volume":"14","author":"Kim","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0110","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1073\/pnas.0402295101","article-title":"Crystal structure of the human T cell receptor CD3\u03b5\u03b3 heterodimer complexed to the therapeutic mAb OKT3","volume":"101","author":"Kjer-Nielsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0115","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071760","article-title":"MHC class I downregulation in cancer: underlying mechanisms and potential targets for cancer immunotherapy","volume":"12","author":"Cornel","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/antib9030049","article-title":"Molecular mechanism of HER2 rapid internalization and redirected trafficking induced by anti-HER2 biparatopic antibody","volume":"9","author":"Cheng","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0130","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.4049\/jimmunol.1203414","article-title":"Relevance of Nck\u2013CD3\u03b5 interaction for T cell activation in vivo","volume":"192","author":"Borroto","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4049\/jimmunol.181.1.243","article-title":"The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling","volume":"181","author":"Tailor","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/1478-811X-7-1","article-title":"Nck adapter proteins: functional versatility in T cells","volume":"7","author":"Lettau","year":"2009","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0145","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa2308743","article-title":"Teplizumab and \u03b2-cell function in newly diagnosed type 1 diabetes","volume":"389","author":"Ramos","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.intimp.2004.09.023","article-title":"Anti-CD3 antibodies OKT3 and hOKT3\u03b31 (ala-ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells","volume":"5","author":"Popma","year":"2005","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.intimp.2005.12.009","article-title":"Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody","volume":"6","author":"Li","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.it.2018.04.008","article-title":"Understanding and manipulating viral immunity: antibody immunodominance enters center stage","volume":"39","author":"Angeletti","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145859_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002620050381","article-title":"Efficiency of T cell triggering by anti-CD3 monoclonal antibodies (mAB) with potential usefulness in bispecific mAB generation","volume":"44","author":"Jacobs","year":"1997","journal-title":"Cancer Immunol. Immunother."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.145859_bb0170","doi-asserted-by":"crossref","first-page":"12807","DOI":"10.1074\/jbc.273.21.12807","article-title":"Characterization of the region involved in CD3 pairwise interactions within the T cell receptor complex","volume":"273","author":"Borroto","year":"1998","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025064141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025064141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T16:07:40Z","timestamp":1755274060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025064141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":34,"alternative-id":["S0141813025064141"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145859","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel CD3\u03b5-specific human antibody for selective modulation of T cell activation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145859"}}